These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14011085)

  • 1. Adjuvant effect of diffusion chambers on soluble antigens.
    ADLER FL; FISHMAN M
    Proc Soc Exp Biol Med; 1962 Dec; 111():691-5. PubMed ID: 14011085
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of adjuvants on the elimination of soluble protein antigens and the associated antibody responses.
    TALMAGE DW; DIXON FJ
    J Infect Dis; 1953; 93(2):176-80. PubMed ID: 13109228
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the enhancing effect of adjuvants on antibody formation in mice.
    HAVAS HF; ANDRE J
    Br J Exp Pathol; 1955 Apr; 36(2):171-4. PubMed ID: 14363579
    [No Abstract]   [Full Text] [Related]  

  • 4. ADJUVANT TO ANTIBIOTIC THERAPY IN STAPHYLOCOCCAL INFECTIONS. A PRELIMINARY INVESTIGATION.
    MCEWEN WW
    J Med Soc N J; 1964 Jun; 61():221-5. PubMed ID: 14145918
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant effect of silica (tridymite) on antibody production.
    PERNIS B; PARONETTO F
    Proc Soc Exp Biol Med; 1962 Jun; 110():390-2. PubMed ID: 14485446
    [No Abstract]   [Full Text] [Related]  

  • 6. FIELD TRIALS OF ADJUVANT AND SALINE INFLUENZA VACCINES.
    HERBERT WJ; SELWYN S; PHILP JR
    Br J Prev Soc Med; 1965 Apr; 19(2):97-100. PubMed ID: 14319217
    [No Abstract]   [Full Text] [Related]  

  • 7. NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE.
    WOODHOUR AF; METZGAR DP; STIM TB; TYTELL AA; HILLEMAN MR
    Proc Soc Exp Biol Med; 1964 Jun; 116():516-23. PubMed ID: 14193390
    [No Abstract]   [Full Text] [Related]  

  • 8. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. II. CLINICAL REACTION AND ANTIBODY RESPONSE.
    STONE S; HU R; KRUGMAN S; TYTELL AA; HILLEMAN MR
    J Allergy; 1963; 34():420-5. PubMed ID: 14066384
    [No Abstract]   [Full Text] [Related]  

  • 9. [IS IT POSSIBLE TO REPLACE ADJUVANT SUBSTANCES IN VACCINES BY COBALT ADMINISTRATION?].
    KATITCH R; STEPHANOVITCH R; DINITCH B; VOUKITCHEVITCH Z; KOSTITCH L
    Rev Immunol Ther Antimicrob; 1964; 28():87-90. PubMed ID: 14187808
    [No Abstract]   [Full Text] [Related]  

  • 10. A NOVEL METHOD OF ENHANCING ANTIBODY PRODUCTION.
    KING LS
    Southwest Med; 1965 Jul; 46():222-4. PubMed ID: 14342680
    [No Abstract]   [Full Text] [Related]  

  • 11. A TRIAL OF OIL-ADJUVANT INFLUENZA VACCINE IN A NON-EPIDEMIC SEASON.
    HOWELL RW; STOTT AN
    Br J Ind Med; 1964 Oct; 21(4):259-64. PubMed ID: 14249893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant action of phosphorylated hesperiden.
    MARTIN GJ; MOSS J; BEILER JM
    Proc Soc Exp Biol Med; 1953 Nov; 84(2):305-6. PubMed ID: 13121021
    [No Abstract]   [Full Text] [Related]  

  • 13. POLIOVIRUS VACCINES IN MINERAL OIL ADJUVANT. I. ANIMAL TOXICITY AND SEROLOGIC RESPONSE DATA.
    HILLEMAN MR; HAMPIL B; SWEET BH
    J Allergy; 1963; 34():413-9. PubMed ID: 14066383
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental neuraxitis caused by general administration of multiple antigens and adjuvants].
    POURSINES Y; TAMALET J
    Mars Med; 1955; 92(10):628-32. PubMed ID: 13308406
    [No Abstract]   [Full Text] [Related]  

  • 15. [Novel adjuvants in vaccine development].
    Kaufmann AM; Schmidt-Ott R; Prechtl A
    MMW Fortschr Med; 2011 Jan; 152 Suppl 4():115-8. PubMed ID: 21598461
    [No Abstract]   [Full Text] [Related]  

  • 16. Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens.
    Mesa C; de León J; Fernández LE
    Vaccine; 2006 Mar; 24(14):2692-9. PubMed ID: 16316710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental encephalomyelitis of the guinea pig following repeated administration by general route of antigen and adjuvants; histologic data].
    POURSINES Y; BRAHIC J
    C R Seances Soc Biol Fil; 1950 Sep; 144(17-18):1198-9. PubMed ID: 14801894
    [No Abstract]   [Full Text] [Related]  

  • 18. [INFLUENCE OF INFLAMMATORY REACTIONS DUE TO KILLED MYCOBACTERIA ON THE TITER OF ANTIBODIES PREVIOUSLY ELABORATED BY GUINEA PIGS AGAINST MUMPS VIRUS].
    HENRY M; SOHIER R; TERRAILLON J
    Rev Immunol Ther Antimicrob; 1964; 28():105-19. PubMed ID: 14232690
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbonyl iron in humoral antibody responses.
    Forbes L; Gruenewald R; Levine S
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):940-3. PubMed ID: 5063369
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant effect of amorphous silica on the immune response to various antigens in guinea pigs.
    Mancino D; Bevilacqua N
    Int Arch Allergy Appl Immunol; 1977; 53(2):97-103. PubMed ID: 191405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.